|
MCM6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47619999999005E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8919499999992E-05 |
| Normal-vs-Stage2 |
1.918630E-01 |
| Normal-vs-Stage3 |
3.51969999999868E-05 |
| Normal-vs-Stage4 |
2.764500E-03 |
| Stage1-vs-Stage2 |
1.341930E-02 |
| Stage1-vs-Stage3 |
6.320600E-01 |
| Stage1-vs-Stage4 |
5.191200E-01 |
| Stage2-vs-Stage3 |
1.205690E-02 |
| Stage2-vs-Stage4 |
1.365790E-01 |
| Stage3-vs-Stage4 |
3.604600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.29479999999116E-05 |
| Normal-vs-AfricanAmerican |
7.355200E-03 |
| Normal-vs-Asian |
3.86689999998246E-06 |
| Caucasian-vs-AfricanAmerican |
4.413400E-01 |
| Caucasian-vs-Asian |
2.103400E-01 |
| AfricanAmerican-vs-Asian |
9.173600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.160000E-03 |
| Normal-vs-Female |
1.620339999997E-05 |
| Male-vs-Female |
1.239380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.43789999995647E-06 |
| Normal-vs-Age(41-60Yrs) |
5.752700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.481800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.614780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.917700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.330160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.086000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.334800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.406000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.332400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.405800E-02 |
| Classical-VS-Follicular |
3.19149999761237E-08 |
| Classical-VS-Other |
8.321600E-02 |
| Classical-VS-Normal |
1.32339999958653E-07 |
| Tall-VS-Follicular |
2.85040000003178E-06 |
| Tall-VS-Other |
1.497790E-02 |
| Tall-VS-Normal |
3.42580000034509E-07 |
| Follicular-VS-Other |
9.230800E-01 |
| Follicular-VS-Normal |
5.261800E-01 |
| Other-VS-Normal |
6.833600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.758300E-04 |
| Normal-vs-N1 |
2.960000E-03 |
| N0-vs-N1 |
8.386200E-01 |
|
|
